Latest Articles
Article
Integrating Sustainability Into the Lab With Martin Farley
Martin Farley, sustainable research adviser at UCL and director of Green Lab Associates, was invited to Technology Networks’ Ask Me Anything session to answer your questions about the future of sustainability in research and laboratory practices.
Article
The Pulse: Psychedelic News From Technology Networks Issue 7
Hello and welcome to the Pulse, the monthly psychedelics industry roundup from Technology Networks and Analytical Cannabis. Here, we’ll highlight some of the most significant psychedelic industry news from the past month, including important announcements, pre-clinical work and the latest from groundbreaking psychedelic clinical trials.
Article
An Introduction to Bayesian Statistics
Bayesian statistics has emerged as a powerful methodology for making decisions from data in the applied sciences. Bayesian brings a new way of thinking to statistics, in how it deals with probability, uncertainty and drawing inferences from an analysis.
Article
Gene Therapy: A New Frontier in Disease-Modifying Therapies
The gene therapy landscape is dynamic and constantly shifting. In this article, we will review major advances in disease modification for illnesses that presently still lack effective treatments, as well as some challenges and approaches to overcome them.
Article
Implanting Microdevices Into Brain Tumors To Determine the Best Treatment
Scientists have demonstrated the potential for using intratumoral microdevices (IMDs) to test various cancer drugs on the tumor before implementing systemic treatment. The approach could offer a hope in tackling hard-to-treat gliomas.
Article
Biomarker Bonanza: Computational Methods and Metabolomics Advances
Biomarkers can potentially aid patient management across the stages of their disease course. This article will review advances in computationally-driven biomarker discovery, including from metabolomics datasets, for complex, multifactorial diseases.
Article
The Power of Placebo in Psychedelic Trials
Ketamine is increasingly used as an antidepressant. A new clinical trial suggests the drug's effects may be may be placebo-based. In this article, we explore what that means for the drug's rollout for ketamine and psychedelic research.
Article
The Quest To Discover the Cell Types of the Brain
In this article, Mike Hawrylycz, an investigator at the Allen Institute for Brain Science, discusses a large, collaborative quest to discover the different cell types of the brain.
Article
The Ultimate Guide to Avoiding Predatory Conferences
Predatory conferences are the ramshackle distant cousin of your regular scientific event, a Fyre Festival of science (without the involvement of Ja Rule). It is getting harder to separate fake conferences from real ones. Given this deluge of dodgy science, we have created a guide to spotting and avoiding predatory conferences.
Article
Cryo Electron Microscopy: Principle, Strengths, Limitations and Applications
Cryo electron microscopy (cryo EM) has revolutionized our understanding of the intricate molecular machinery that governs life. In this article, we discuss what cryo EM is, how it works, it's strengths, limitations and applications.
Advertisement